Stockscreener 앱 받기
4.46
2.53%
0.11
시간 외 거래:
4.63
0.17
+3.81%
전일 마감가:
$4.35
열려 있는:
$4.355
하루 거래량:
150.65K
Relative Volume:
1.70
시가총액:
$22.16M
수익:
$755.00K
순이익/손실:
$-9.33M
주가수익비율:
-0.7811
EPS:
-5.71
순현금흐름:
$-5.43M
1주 성능:
+14.07%
1개월 성능:
+3.00%
6개월 성능:
+18.93%
1년 성능:
+50.55%
1일 변동 폭
$4.355
$5.0107
1주일 범위
$3.2101
$5.0107
52주 변동 폭
$2.07
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
명칭
Mangoceuticals Inc
전화
(833) 626-4679
주소
15110 DALLAS PKWY, SUITE 600, DALLAS
MGRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
4.46 | 22.16M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
236.77 | 38.44B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
73.97 | 12.80B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
62.99 | 11.82B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
51.35 | 8.84B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
84.88 | 7.36B | 1.15B | 96.70M | -161.99M | 1.09 |
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
Mangoceuticals Inc. (MGRX) reports earnings - Quartz
MANGOCEUTICALS, INC. SEC 10-K Report - TradingView
Mangoceuticals (NASDAQ:MGRX) Shares Up 18% – Time to Buy? - Defense World
Mangoceuticals Announces Equity and Leadership Changes By Investing.com - Investing.com Australia
Mangoceuticals, Inc. Approves Key Amendments at Special Meeting - TipRanks
Mangoceuticals Announces Equity and Leadership Changes - Investing.com
Mangoceuticals advances in H1N1 and H5N1 studies - MSN
Mangoceuticals, Inc. Now Featured on Webull Corporate Communications Service Platform - ACCESS Newswire
Shares of Healthcare Company Rise Following Product Availability Announcement - MSN
Mangoceuticals Launches PeachesRx, A Women's Telehealth Brand For Wellness And GLP-1 Treatments - Nasdaq
Mangoceuticals Announces the Launch of “PeachesRx”a - GlobeNewswire
Mangoceuticals rises on launch of women's telehealth brand - TradingView
Mangoceuticals launches PeachesRx women’s telehealth brand - TipRanks
This New Women's Health Platform Could Disrupt the $48B GLP-1 Weight Loss Market - StockTitan
Mangoceuticals Inc. issues stock for consulting services By Investing.com - Investing.com South Africa
Mangoceuticals Inc. issues stock for consulting services - Investing.com
Mangoceuticals (MGRX): A Low Float Stock on the Verge of a Short Squeeze? - Small Cap Exclusive
Mangoceuticals (NASDAQ:MGRX) versus Quipt Home Medical (NASDAQ:QIPT) Head to Head Analysis - Defense World
Mangoceuticals targets avian flu with water-based solution By Investing.com - Investing.com Nigeria
Mangoceuticals Advances Research on Avian Flu Treatment for Poultry Industry - Defense World
Mangoceuticals targets avian flu with water-based solution - MSN
Mangoceuticals, Inc. Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology - Marketscreener.com
Mangoceuticals Advances Research On Avian Flu Solution For Poultry -February 12, 2025 at 08:19 am EST - Marketscreener.com
Mangoceuticals Advances Antiviral Research on its Patented - GlobeNewswire
Revolutionary Water-Based Solution Shows Promise in Fighting Bird Flu CrisisPhase I Results Reveal Major Breakthrough - StockTitan
Mangoceuticals Inc (MGRX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Mangoceuticals (NASDAQ: MGRX): A High-Growth Play With Multiple Catalysts - Small Cap Exclusive
Mangoceuticals Expands COO Role and Increases Compensation - TipRanks
Mangoceuticals Advances H1N1 Efficacy Study Noting - GlobeNewswire
Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research - The Manila Times
Mangoceuticals advances in H1N1 and H5N1 studies By Investing.com - Investing.com UK
Major H1N1 Treatment Success: Mangoceuticals' Novel Antiviral Shows Promise Against Bird Flu - StockTitan
Mangoceuticals executes exclusive distribution agreement with Propre - TipRanks
Mangoceuticals Signs Exclusive Distribution Deal With Propre Energie For Dermytol - Nasdaq
Mangoceuticals, Inc. Executes Exclusive Distribution - GlobeNewswire
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com
Mangoceuticals, Inc. Announces Closing of $5 Million Initial Public Offering - ACCESS Newswire
MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market - ACCESS Newswire
Mangoceuticals, Inc. Finalizes Debt Conversion and Appointments - TipRanks
Mangoceuticals alters stockholder rights, amends bylaws - MSN
Mangoceuticals alters stockholder rights, amends bylaws By Investing.com - Investing.com Canada
Mangoceuticals, Inc. announced that it has received $0.55 million in funding - Marketscreener.com
Erectile Dysfunction Treatment Market Future Business - openPR
Mangoceuticals, Inc. announced that it has received $0.05 million in funding - Marketscreener.com
Mangoceuticals, Inc. announced that it has received $0.3 million in funding - Marketscreener.com
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Investors - Defense World
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Accredited Investors - Defense World
Mangoceuticals Inc (MGRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.23%
2.11%
자본화:
|
볼륨(24시간):